MUCCIOLI, Giampiero Gerardo
 Distribuzione geografica
Continente #
EU - Europa 8.480
NA - Nord America 7.928
AS - Asia 4.218
SA - Sud America 641
Continente sconosciuto - Info sul continente non disponibili 443
AF - Africa 118
OC - Oceania 26
Totale 21.854
Nazione #
US - Stati Uniti d'America 7.654
IT - Italia 4.632
SG - Singapore 1.799
CN - Cina 1.116
FR - Francia 588
BR - Brasile 496
DE - Germania 492
VN - Vietnam 452
UA - Ucraina 445
IE - Irlanda 435
SE - Svezia 383
FI - Finlandia 330
NL - Olanda 308
KR - Corea 301
GB - Regno Unito 202
AT - Austria 193
PL - Polonia 168
CA - Canada 145
HK - Hong Kong 108
IN - India 78
JP - Giappone 78
BD - Bangladesh 67
MX - Messico 66
RU - Federazione Russa 66
AR - Argentina 52
DK - Danimarca 52
BE - Belgio 38
IQ - Iraq 28
TR - Turchia 28
CO - Colombia 27
ID - Indonesia 27
ES - Italia 26
UZ - Uzbekistan 25
ZA - Sudafrica 24
EC - Ecuador 23
AU - Australia 19
JM - Giamaica 17
SN - Senegal 17
AL - Albania 16
CH - Svizzera 16
IR - Iran 15
PK - Pakistan 15
GR - Grecia 14
MA - Marocco 14
DZ - Algeria 13
PH - Filippine 13
CZ - Repubblica Ceca 12
EG - Egitto 12
CL - Cile 10
JO - Giordania 10
TN - Tunisia 10
EU - Europa 9
RO - Romania 9
SA - Arabia Saudita 9
TW - Taiwan 9
VE - Venezuela 9
PE - Perù 8
CR - Costa Rica 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
PY - Paraguay 7
BG - Bulgaria 6
HU - Ungheria 6
KE - Kenya 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
HR - Croazia 5
LT - Lituania 5
MY - Malesia 5
NG - Nigeria 5
NO - Norvegia 5
RS - Serbia 5
TH - Thailandia 5
AZ - Azerbaigian 4
HN - Honduras 4
PR - Porto Rico 4
SV - El Salvador 4
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MK - Macedonia 3
MU - Mauritius 3
NP - Nepal 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CG - Congo 2
CV - Capo Verde 2
CY - Cipro 2
GA - Gabon 2
KW - Kuwait 2
LV - Lettonia 2
MT - Malta 2
SM - San Marino 2
AF - Afghanistan, Repubblica islamica di 1
Totale 21.398
Città #
Singapore 964
Beijing 699
Santa Clara 629
Chandler 605
Ashburn 500
Milan 484
Dublin 434
Rome 394
San Jose 369
Villeurbanne 316
Houston 263
Jacksonville 261
Ann Arbor 204
Vienna 183
Dearborn 164
The Dalles 164
Warsaw 154
Medford 151
Naples 150
Princeton 147
Columbus 139
Nyköping 136
Turin 117
Lauterbourg 114
Ho Chi Minh City 113
Los Angeles 112
Dallas 107
New York 104
Bologna 101
Hong Kong 99
Wilmington 95
Fairfield 91
Buffalo 89
Munich 83
Hanoi 80
Palermo 79
Torino 75
Bari 72
Boston 71
Florence 65
Verona 65
Boardman 63
Catania 55
Redwood City 48
Pescara 47
Woodbridge 46
Fremont 43
Helsinki 42
Tokyo 41
Seattle 40
São Paulo 40
Toronto 39
Cambridge 38
Council Bluffs 36
Brescia 35
Genoa 35
Atlanta 34
Frankfurt am Main 32
Trieste 31
Dong Ket 30
Pisa 30
Seoul 30
Orem 29
Brussels 28
Guangzhou 28
Venice 28
London 27
Messina 27
Cagliari 24
Hefei 24
L’Aquila 23
Norwalk 23
Parma 23
Longmont 22
Rio de Janeiro 22
Turku 22
Monza 21
Shanghai 21
Chicago 20
Da Nang 20
Falls Church 19
Haiphong 19
Nanjing 19
Philadelphia 19
Phoenix 19
Lachine 18
Modena 18
Perugia 18
Padua 17
Washington 17
Bergamo 16
Figino 16
Seongnam 16
Tirana 16
Amsterdam 15
Brooklyn 15
Jakarta 15
Montreal 15
San Francisco 15
Catanzaro 14
Totale 10.845
Nome #
Farmacologia generale e clinica 4.424
Alkaloid Profiles and Activity in Different Mitragyna speciosa Strains 636
Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin 515
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans 492
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines 428
Farmacologia generale e clinica 380
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 374
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV 281
Ghrelin and Des-Acyl Ghrelin Promote Differentiation and Fusion of C2c12 Skeletal Muscle Cells 276
Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. 231
ACYLATED AND UNACYLATED GHRELIN PROMOTE PROLIFERATION AND INHIBIT SERUM STARVATION- AND CYTOKINE-INDUCED APOPTOSIS OF PANCREATIC BETA-CELLS AND HUMAN ISLETS. INVOLVEMENT OF cAMP/PKA, ERK1/2 AND PI3K/AKT SIGNALING 229
Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B. 185
A sensitive experimental model for the assessment of hepatotoxicity by halogenocompounds: prolactin binding to the specific receptors 173
Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling 170
Growth hormone-releasing peptides. 167
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences 161
Ghrelin: endocrine, metabolic and cardiovascular actions 161
Cardiac effects of hexarelin in hypopituitary adults. 158
Biologic activities of growth hormone secretagogues in humans. 156
Biochemical study of prolactin binding sites in Xenopus laevis brain and choroid plexus 156
Boosting the efficacy of doxorubicin against ovarian cancer by ultrasound stimulation 156
Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats 149
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma 148
Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes 148
Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function 148
Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland 146
Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans 145
Growth hormone secretagogue binding sites in peripheral human tissues. 145
Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 smal cell carcinoma cell line 144
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors 143
[Pharmacological research on various derivatives of 2H,3H-benzimidazo(1,2,-b)oxazole] 141
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. 141
Correlative studies on the presence of oestrogen and prolactin receptors and histology in human breast carcinomas 140
Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin 138
Presence of cortistatin in the human pancreas. 137
Prolactin receptor and interrenal hormone levels in adult Xenopus laevis (Daudin) exposed to hyperosmotic stress and treated with metyrapone. 136
Ghrelin: much more than a natural growth hormone secretagogue. 135
Ghrelin and prostate cancer 132
EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. 132
Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland. 129
Further study on the changes in the concentration of prolactin-binding sites in different organs of Xenopus laevis male and female, kept under dry conditions and then returned to water (their natural habitat) 128
CARDIOVASCULAR ACTIVITIES OF NATURAL AND SYNTHETIC GH SECRETAGOGUES 127
Brain-gut communication: cortistatin, somatostatin and ghrelin 127
Somatostatin, cortistatin and their receptors in tumours 126
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans 126
Insulin-like growth factor binding protein-3 mediates serum starvation- and doxorubicin-induced apoptosis in H9c2 cardiac cells. 125
Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits. 123
Ormoni dell’ipofisi posteriore 122
Prolactin and interrenal hormone balance in adult specimens of Xenopus laevis exposed to hyperosmotic stress for up to one week. 122
Beyond the metabolic role of ghrelin: a new player in the regulation of reproductive function 122
Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic beta-cells 122
Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans 122
Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. 119
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. 118
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. 117
GENERAL ANESTHESIA ABOLISHES THE ENDOCRINE BUT NOT THE CARDIOVASCULAR ACTIVITIES OF HEXARELIN, A GHRP, IN HUMANS 117
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21. 117
Effetto di GH e/o IGF-I esogeni sulla crescita di colture primarie di fibroblasti di pazienti ustionati. 116
The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans 115
TYR-ALA-HEXARELIN, A SYNTHETIC OCTAPEPTIDE, HAS THE SAME ENDOCRINE ACTIVITIES OF HEXARELIN AND GHRP-2 IN HUMANS 115
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. 115
Pharmacological and biochemical characterization of TLQP-21 activation of a binding site on CHO cells 114
Hyperprolactinaemia and prolactine binding in benign intracranial tumours. 114
Prolactin receptors in human meningiomas: characterization and biological role. 113
Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors 113
Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. 113
Prolactin and interrenal hormone balance in Xenopus laevis adult specimens adapted to brackish water. 113
Ghrelin: a metabolic signal affecting the reproductive system 106
Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor 106
New active series of growth hormone secretagogues. 104
Known and unknown growth hormone secretagogue receptors and their ligands 104
Farmacologia degli ormoni dell'ipofisi posteriore 104
Growth hormone secretagogues, synthesis and biological evaluation 103
Endocrine and non-endocrine actions of ghrelin and GHS: state of the art in clinic research. 103
Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours 103
Prolactin binding sites in Xenopus laevis tissues: comparison between normal and dehydrated animals 103
Preliminary results on prolactin binding sites in Xenopus laevis brain and choroid plexus studied by radioautographic analysis. Difficulties and limits of the research. 102
Farmacologia degli ormoni ipotalamici 102
Prolactin receptors in human pituitary adenomas. 101
Natural and synthetic growth hormone secretagogues: do they have therapeutic potential? 100
Specific prolactin binding to rabbit brain membranes. 100
Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery. 100
Farmacologia degli ormoni ipotalamici 97
Endocrine responses to GH secretagogues in relation to sex and age in humans 97
Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. 97
Medroxyprogesterone acetate (MPA) stimulates adenylate cyclase activity in rat mammary tumours. 96
Prolactin receptors in human choroid plexus. 96
Des-Acyl Ghrelin Has Specific Binding Sites and Different Metabolic Effects from Ghrelin in Cardiomyocytes 94
Growth hormone-releasing peptides and the cardiovascular system. 93
The dopaminergic system and breast disease: novel approaches to pathophysiology and treatment. 93
Endocrine activities of alexamorelin (Ala-His-d-2-methyl-Trp-Ala-Trp-d-Phe-Lys-NH2), a synthetic GH secretagogue, in humans 92
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. 92
Normal development of lymphokine activated killing (LAK) in peripheral blood lymphocytes from hyperprolactinemic patients. 90
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 90
The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. 90
Modification of prolactin receptor levels induced by pharmacological treatments in R3230AC rat mammary tumors. 90
Natural and synthetic growth hormone-releasing peptides. 89
Targeting the ghrelin receptor: orally active GHS and cortistatin analogs. 89
Effects of long-term administration of high doses of medroxyprogesterone acetate on hormone receptors and target organs in the female rat. 89
Pharmacokinetics of oxametacine, a new non-steroidal anti-inflammatory agent 88
Totale 19.010
Categoria #
all - tutte 58.856
article - articoli 0
book - libri 0
conference - conferenze 5.795
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.089 0 39 55 39 42 39 64 68 53 72 284 334
2022/20232.270 204 143 61 230 243 516 184 170 260 73 116 70
2023/20241.209 135 144 93 156 71 132 71 80 22 54 97 154
2024/20253.840 51 231 152 400 840 242 162 244 507 296 301 414
2025/20266.817 579 307 533 747 569 296 885 329 567 505 454 1.046
2026/20271.379 785 594 0 0 0 0 0 0 0 0 0 0
Totale 21.854